BioSpace News Archive

Policy

Asuragen Announces CE Mark of AmplideX® SMA Plus Kit

The assay is intended to aid in the diagnosis of and identification of carriers for spinal muscular atrophy (SMA)

July 7, 2020
·
3 min read
Therapeutic Homecare Devices Market promises profitable business opportunities in the near future

Various studies conducted recently contend that rehabilitation treatments and therapeutic devices offered at home settings are equally effective as compared to hospitals for a number of surgeries.

July 7, 2020
·
5 min read
Business

Mogrify Adds Dr. Lorenz Mayr to Board of Directors and Scientific Advisory Board

Mogrify Ltd, a UK biotechnology company aiming to transform the development of cell therapies by the systematic discovery of novel cell conversions, announced the appointment of Lorenz Mayr, PhD, to the Board of Directors and the Scientific Advisory Board.

July 7, 2020
·
2 min read
Policy

Nemaura Medical Submits PMA Application for sugarBEAT® to U.S. FDA

Company to Participate in RedChip Webinar on Tuesday, July 7, at 11 a.m. ET to Discuss Commercialization Progress.

July 7, 2020
·
4 min read
Cybrexa Therapeutics Completes Successful Pre-IND Meeting With FDA for CBX-12 (alphalex™-exatecan), a Novel Treatment for Solid TumorsPositive pre-IND Meeting with FDA supports plan to file IND in fourth quarter 2020

NEW HAVEN, Conn., July 07, 2020 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ tumor targeting platform, today announced that it successfully completed a pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding its proposed IND and Phase I/II study for its lead candidate, CBX-12 (alphalex™-exatecan). Cybrexa plans to submit the IND application for CBX

July 7, 2020
·
3 min read
Pharm Country

BD Launches First and Only Fully Sterile Povidone-Iodine and Isopropyl Alcohol Skin Preparation

New BD PurPrep™ skin preparation is the only commercially available PVP-I antiseptic skin preparation with sterile solution in the U.S.

July 7, 2020
·
4 min read
Pharm Country

Tonix Pharmaceuticals Plans Massachusetts R&D Facility to Accelerate Clinical Development of Vaccines and Protein-Based Therapeutics

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced its intent to purchase an approximately 40,000 square foot facility in Massachusetts to use as laboratories to enable R&D functions associated with its expanding portfolio of immunology candidates, including vaccines for COVID-19 and biological products for other disorders.

July 7, 2020
·
6 min read
Business

Syndax Pharmaceuticals Appoints Daphne Karydas as Chief Financial Officer

Syndax Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced the appointment of Daphne Karydas as Chief Financial Officer, effective July 13, 2020.

July 7, 2020
·
5 min read
Biotech Beach

Ionis Pharmaceuticals to hold neurology franchise webcast

Ionis Pharmaceuticals, Inc. announced that it will host a live webcast on Tuesday, July 14th at 10:00 a.m. Eastern Time to review its neurology franchise.

July 7, 2020
·
2 min read
Biotech Beach

Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement For Repotrectinib in Greater China

Zai Lab Granted Exclusive Rights to Develop and Commercialize Repotrectinib in Greater China

July 7, 2020
·
9 min read